Reefrad, I've always said it was only speculation and while NWBO didn't even attend ASCO this year, last year when they did, their booth blasted the message that our vaccine is tumor agnostic.
Dr. Ashkan, who's clearly highly respected in the UK could certainly testify to the benefits he's seen there in treating patients with other cancers under compassionate use. All I'm saying is that so much seems to be happening in the UK that I believe it's possible.
To me, that, and the approval of the EDEN unit, would explain why their action is taking so long. A decision on a simple approval for GBM alone shouldn't take nearly two years.
Gary
Bullish
Market Data 
Markets 
AI
